{"prompt": "['2016N277425 00', 'CONFIDENTIAL', '2018N377698_00', 'GlaxoSmithKline group of companies', '201749', 'TITLE PAGE', 'Division: Worldwide Development', 'Information Type: Clinical Protocol', 'Title:', 'A 24-week treatment, multi-center, randomized, double-blind,', 'double-dummy, parallel group study to compare', 'Umeclidinium/Vilanterol Umeclidimium, and Salmeterol in', 'subjects with chronic obstructive pulmonary disease (COPD)', 'Compound Number:', 'GSK2592356', 'Development Phase', 'IV', 'Effective Date:', '13-SEP-2016', 'Author(s): PPD', 'Copyright 2016 the GlaxoSmithKline group of companies. All rights reserved.', 'Unauthorised copying or use of this information is prohibited.', '1']['2018N377698_00', '2016N277425_00', 'CONFIDENTIAL', '201749', 'SPONSOR SIGNATORY:', 'PPD', '13 sept. 2016', 'Davia Dipson,', 'Date', 'GSK', 'PPD', 'PPD', '2']['2016N277425_00', 'CONFIDENTIAL', '2018N377698_00', '201749', 'MEDICAL MONITOR/SPONSOR INFORMATION PAGE', 'Medical Monitor/SAE Contact Information:', 'Role', 'Name', 'Day Time Phone', 'After-hours', 'Fax', 'Site Address', 'Number and email', 'Phone/Cell/', 'Number', 'address', 'Pager', 'Number', 'Primary', 'PPD', 'Telephone: PPD', 'Cell: PPD', 'Fax: PPD', 'GlaxoSmithKline', 'Medical', 'PPD', 'Stockley Park', 'Monitor', 'West, 1-3', 'Ironbridge Road,', 'Heathrow,', 'Uxbridge,', 'Middlesex, UB11', '1BT, United', 'Kingdom', 'Secondary', 'PPD', 'MD', 'Cell:', 'Fax:', 'GlaxoSmithKline', 'Medical', 'Telphone: PPD', 'Stockley Park', 'Monitor', 'PPD', 'West, 1-3', 'Ironbridge Road,', 'Heathrow,', 'Uxbridge,', 'Middlesex, UB11', '1BT, United', 'Kingdom', 'SAE', 'Telephone: PPD', 'Cell: PPD', 'Fax: PPD', 'GlaxoSmithKline', 'contact', 'PPD', 'Stockley Park', 'information', 'West, 1-3', 'Ironbridge Road,', 'Heathrow,', 'Uxbridge,', 'Middlesex, UB11', '1BT, United', 'Kingdom', 'Sponsor Legal Registered Address:', 'GlaxoSmithKline Research & Development Limited', '980 Great West Road', 'Brentford', 'Middlesex, TW8 9GS', 'UK', 'In some countries, the clinical trial sponsor may be the local GlaxoSmithKline Affiliate', 'Company (or designee). If applicable, the details of the alternative Sponsor and contact', '3']\n\n###\n\n", "completion": "END"}